About
Cognitive Health Program
Our Founder
Resources
Bredesen Protocol
ReCODE Report
Alzheimer's Prevention
The Subtypes of Alzheimer's Disease
What is ApoE?
Dietitian, Nutritionist or Health Coach
Pricing
FAQs
Blog
Contact Us
Sign Up
Log In
News
Breaking headlines and noteworthy information regarding cognitive health and the Bredesen Protocol.
Recipes
Bredesen Protocol approved recipes curated by our registered dietitian nutritionists.
Nutrition
Stay current with the latest research for optimizing and personalizing your nutrition plan.
Lifestyle
Exercise, sleep, stress management techniques and more to improve your brain and overall health.
News
What is Traumatic Alzheimer's Disease?
Traumatic Alzheimer’s is the fifth subtype of Alzheimer’s disease that is characterized by a history of head trauma and a subsequent, often earlier, onset of Alzheimer’s disease.
News
What is Vascular Alzheimer's Disease?
Vascular Alzheimer’s is the fourth subtype of Alzheimer’s disease that is characterized by the presence of cardiovascular risk factors and reduced blood flow to the brain.
News
What is Glycotoxic Alzheimer's Disease?
Glycotoxic Alzheimer's is a combination of type 1 and type 2, referred to as subtype 1.5. This subtype is characterized by blood sugar dysregulation, chronic inflammation, and hormonal imbalances.
News
What is Atrophic Alzheimer's Disease?
Atrophic Alzheimer’s is the second subtype of Alzheimer’s disease wherein the brain begins to downsize in response to a lack of hormonal and trophic support.
News
What is Inflammatory Alzheimer's Disease?
Inflammatory Alzheimer’s is the first subtype of Alzheimer’s disease that is characterized by the presence of chronic inflammation in the body and the brain.
News
What is Toxic Alzheimer's Disease?
In this post, we will discuss the causes, signs, symptoms, and treatment of toxic Alzheimer’s disease.
News
You Can Reverse Your Biological Age
It definitely sounds too good to be true, but new research shows that we can in fact reverse biological aging with diet and lifestyle.
News
Does Prevagen Improve Memory Loss?
Prevagen’s story is one of corruption, greed, and exploitation. This supplement which claims to improve memory is based on disingenuous research and comes with risky side effects.
News
Top 5 Blog Posts of 2021
For our final blog post in 2021, we want to share with you the 5 top performing blog posts of the last year.
News
Amos Institute Publishes Article About Zinc and COVID-19
We are so pleased to share our manuscript which was published this month in the peer-reviewed journal, Annals of Medicine, entitled Association Between COVID-19 and Angiotensin-Converting Enzyme Inhibitors with the Spotlight on Zinc
News
What is the Glymphatic System?
It was recently discovered that cerebrospinal fluid, a fluid made in the ventricles of the brain and primarily known to act as a cushion for the brain, also acts as as the brains very own lymphatic system, which is known as the glymphatic system.
News
“The First Survivors of Alzheimer’s”: What’s in the New Book by Dr. Dale Bredesen
In this post we review Dr. Dale Bredesen's newest book which comes out this week.
News
Did Your 23andMe Show the ApoE4 Variant?
If you have just found out that you carry ApoE4 through your 23andMe Late-Onset Alzheimer’s Disease Genetic Health Risk report, don’t panic. Carrying 1 or even 2 copies of ApoE4 does not mean you will develop late-onset Alzheimer’s disease if you act now!
News
Aducanumab: A Call to Action
We believe the approval of aducanumab is outrageous and is a danger to both our healthcare system and families who are fighting Alzheimer’s disease. We are encouraging our community to educate themselves on this important issue, and to speak out about this catastrophe.
News
Continued Backlash Following FDA Approval of Aducanumab
Last week we wrote about the surprising FDA approval of the ineffective Alzheimer’s drug aducanumab. Since then, this story has continued to unravel, sparking more and more controversy as time goes on.
News
FDA Approves Alzheimer’s Drug that Research Shows Does Not Work
According to the research this drug, which will be called by its brand name Aduhelm, does not work in slowing or stopping the progression of Alzheimer’s disease, despite its approval by the FDA.
News
Therapeutic Uses of Hibiscus in Treating Common Chronic Diseases
The Amos Institute Team is proud to have authored a recent publication in the Journal of the American College of Nutrition, entitled “Mechanisms of Action of Nutritionally Rich Hibiscus sabdariffa’s Therapeutic Uses in Common Chronic Diseases: a Literature Review.”
News
Top 3 Blog Posts of 2020
For our final blog post of 2020, we want to share with you the top 3 blog posts from this year.
News
Biogen’s Alzheimer’s Drug, Aducanumab, Rejected By FDA
Last week, an FDA panel rejected arguments in favor of Biogen's highly anticipated drug, aducanumab.
News
Chronological vs. Biological Aging and Disease
Individuals with the same chronological age may vary in their rate of aging, indicating that biological age is more beneficial in determining health status. Although it seems that pain medication and chronic diseases are inevitable aspects of aging, the science implies a different story.
News
The Impact of Obesity on Alzheimer’s Disease
Research shows that people with a higher BMI during midlife have a greater risk for developing Alzheimer’s. One mechanism behind this connection is that diet induced obesity has been shown to increase the permeability of the blood-brain barrier.
News
“The End of Alzheimer’s Program”, What’s in the New Book by Dr. Dale Bredesen
Here we review Dr. Dale Bredesen's new book, “The End of Alzheimer's Program” which comes out later this month.
News
The Effect of Socioeconomic Status on Alzheimer’s Disease
There is increasing research that indicates being in a low socioeconomic bracket increases the risk of developing Alzheimer’s disease.
News
Refined Carbohydrate Intake Increases Alzheimer’s Risk in ApoE4 Carriers
Recent research found that ApoE4 carriers who ate an afternoon snack with a high glycemic load were twofold to threefold more likely to develop dementia.
News
The Functional Approach to Treating COVID-19
Published in Integrative Medicine, a new article identifies four different phases which follow the progression of COVID-19, each with differing interventions: prevention, infection, inflammation, and recovery.
News
The Link Between Gluten and Cognitive Function
Gluten free diets are highly controversial. If you have Alzheimer’s disease, should you be on a gluten free diet?
News
Research Suggests Black Tea Inhibits COVID-19
Preliminary research shows that drinking black tea may help inhibit the COVID-19 virus maturation and progression.
News
The Link Between Diabetes and Alzheimer’s Disease
Diabetes pathophysiology is thought to contribute to a subset of Alzheimer’s disease known as Glycotoxic Alzheimer’s.
News
The Emotional Burden of Dementia & The Benefits of Community
Alzheimer’s disease takes a massive emotional toll on both the individual suffering from the diagnosis and on their loved ones. Having the support of the community can help.
News
DIAN-TU Trial: Another Failed Monotherapy for Alzheimer’s
This past week, news broke that yet another massively anticipated Alzheimer’s drug trial has failed.
News
What is Alzheimer's Disease?
There are dozens of things that lead to the same imbalance that we refer to as Alzheimer’s disease.
News
Big Verdicts in Monsanto’s Roundup Cancer Suits
There are more than 13,000 court cases against Monsanto and the big verdicts are coming in for Glyphosate victims.
News
Epigenetics and Alzheimer's Disease
Epigenetics refers to changes caused by modification of gene expression rather than alteration of the genetic code itself.
News
Plastic Straws and BPA Exposure
It is estimated that 500 million disposable plastic straws are used in the United States every single day.
News
Why Aren't Current Medicines an Effective Treatment for Alzheimer's Disease?
Alzheimer’s drug development has the highest failure rate of any other disease. In this video clip, Dale Bredesen, MD explains why.
News
Dale Bredesen Talks About the Origins of the Bredesen Protocol
In honor of International Women's Day, here we highlight the impact of one woman who had a profound influence on the development of the Bredesen Protocol.
News
2018 in Review: Nutrition and Cognition
With each year we put a few more more pieces of the complex puzzle of human health together. Here we review some of 2018’s most compelling articles on nutrition and cognition.
News
Reversal of Cognitive Decline in 100 Patients Using the Bredesen Protocol
Dale Bredesen and practitioners from 15 clinical sites published documentation of 100 patients following the Bredesen Protocol who demonstrated a reversal of cognitive decline.
News
The Safety and Regulation of Botanical Supplements
Botanicals have been used as medicine for centuries, but are popular botanical supplements safe to use?
News
Trader Joe's Wild Salmon
Is the wild frozen salmon from Trader Joe's actually wild-caught?
News
Introducing Purple Tea
Purple tea has a higher level of anthocyanins than any other tea! Pour yourself a cup today to get the benefits!
News
The 2018 Dirty Dozen and Clean Fifteen
The EWG has announced the Dirty Dozen and Clean Fifteen for 2018. Read on for the consumer guide to buying organic produce.
News
Amos Institute Interview on "The Sitch"
Check out our interview with Registered Dietitian, Whitney English. We talk all things nutrition and brain health for Brain Awareness Week!
News
What is Functional Medicine?
Functional Medicine is the future of medicine and health management.
News
The End of Alzheimer's
Dale Bredesen challenges our conventional medicine view of Alzheimer’s disease with revolutionary research and an evidence based protocol proven to prevent and reverse cognitive decline.
News
Announcing the Amos Institute Blog
Our blog is your go-to resource for all things cognitive health and general wellness. On the blog, we will be sharing healthy lifestyle tips, nutrition information, delicious recipes, and other Amos Institute news.